Inflammatory bowel disease mucosal biopsies have specialized lymphokine mRNA profiles

Inflammatory Bowel Diseases

Volumn 2, Issue 1, 1996, Pages 16-26

  Mullin, Gerard E ^a   Maycon, Zev R ^a   Braun Elwert, Lorenz ^b   Cerchia, Reneé ^a   James, Stephen P ^c   Katz, Seymour ^a   Weissman, Gary S ^a   McKinley, Matthew J ^a   Fisher, Stanley E ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammatory bowel disease; Lymphokine profiles; T helper cell

Indexed keywords

EID: 0001779218     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1002/ibd.3780020105     Document Type: Article

References (53)

1. Kirshner JB, Shorter RG. Recent developments in "nonspecific" inflammatory bowel disease. N Engl J Med 1982;306: 775-85, 837-48.
2. Yardley JH, Donowitz M. Colo-rectal biopsy in inflammatory bowel disease. In: Yardley JH, Morson BC, Abell MR, eds. The gastrointestinal tract. Baltimore: Williams and Wilkins, 1977:50-94.
3. Strober W, James SP. The immunological basis of inflammatory bowel disease. J Clin Immunol 1986;6:415-32.
4. Sartor RB. Pathogenic and clinical relevance of cytokines in inflammatory bowel disease. Immunol Res 1991;10:465-71.
5. Schreiber S, MacDermott RP, Raedler A, Pinnau R, Bertovich MJ, Nash GS. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology 1990;101:1020-30.
6. James SP, Mullin GE, Kanof ME, Zeitz M. Role of lymphokines in immunoregulatory function of mucosal T cells in humans and nonhuman primates. Immunol Res 1991;230-8.
7. Fais S, Pallone F. Ability of human colonic epithelium to express the 4F2 antigen, the common acute lymphoblastic leukemia antigen, and the transferin receptor. Gastroenterology 1989;97:1435-41.
8. Pallone F, Fais S, Squarcia O, Biancone L, Pozzilli P, Boirivant M. Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease: in vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens. Gut 1987;28:745-53.
9. Brynskov J, Freund L, Rasmussen SN, Lauritsen K, de-Muckadell OS, et al. A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med 1989;321:845-50.
10. Cherwinski HM, Schumacher JH, Brown KD, Mosmann TR. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 1987;166:1229.
11. Byrne JA, Butler JL, Cooper MD. Differential activation requirements for virgin and memory T cells. J Immunol 1988;141:3249.
12. + T-cell subsets producing a selective pattern of lymphokines in the pathogenesis of human chronic inflammatory and allergic diseases. Immunol Rev 1991;123:23-35.
13. Yssel H, Shanafelt MC, Soderverg C, Schneider PV, Anzola J, Peltz G. Borrelia burgdorderi activates a T helper type 1-like T cell subset in Lyme arthritis. J Exp Med 1991;174: 593-601.
14. Uyemura K, Ohmen JD, Grisso CL, Sieling PA, Wyzykowski R, Reisinger DM, Rea TH, Modlin RL. Limited T-cell receptor-chain diversity of a T-helper cell type 1-like response to mycobacterium leprae. Infect Immun 1992;60:4542-8.
15. Lahesmaa R, Yssel H, Batsford S, Luukkainen R, Motonen T, Steinman L, Peltz G. Yersinia enterocolitia activates a T helper type 1-like cell subset in reactive arthritis. Immunology 1992;148:3079-85.
16. Schlaak J, Hermann E, Ringhoffer M, Probst P, Gallati H, Neyerzum KH, Fleischer B. Predominance of Th1-type T cells in synovial fluid of patients with Yersinia-induced reactive arthritis. Eur J Immunol 1992;22:2771-6.
17. Niemialtowski MG, Rouse BT. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J Immunol 1992;149:3035-9.
18. Paronchi P, DeCarli M, Mannetti R, Simonelli C, Piccinni MP, Macchia D, Maggi E, Delprete G, Ricci M, Romagnani S. Aberrant interleukin (IL)-4 and IL-5 production in vitro by CD4+ helper T cells from atopic subjects. Eur J Immunol 1992;22:1615-20.
19. Fiocchi C. Production of inflammatory cytokines in the intestinal lamina propria. Immunol Res 1991;10:239-46.
20. Mullin GE, Lazenby AJ, Harris ML, Bayless TM, James SP. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 1992;102:1620-7.
21. Duchmann R, Strober W, James SP. Quantitative measurement of human T-cell receptor Vβ subfamilies by reverse transcription-polymerase chain reaction using synthetic internal mRNA standards. DNA Cell Biol 1993;12:217-25.
22. Robinson BWS, McLemore TL, Crystal RG. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in T lymphocytes from patients with pulmonary sarcoidosis. J Clin Invest 1985;75:1488-95.
23. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat. Gastroenterology 1989;96: 795-803.
24. Yamada T, Sartor RB, Marshall S, Grisham MB. A chronic model of distal colitis induced by bacterial cell wall polymers: activation of leukocyte nitric oxide synthesis. Gastroenterology 1992;102:716.
25. Lionetti P, Breese E, Braegger CP, Murch SH, Taylor J, MacDonald T. T cell activation can induce either mucosal destruction of adaptation in cultured human fetal small intestine. Gastroenterology 1993;105:375-81.
26. Scott P, Natovitz P, Coffman RL, Pearce E, Sher A. Immunoregulation of cutaneous leishmaniasis: T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med 1988;168:1675.
27. Heinzel FP, Sadick MD, Holady BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon-γ or interleukin 4 during the resolution or progression of murine leishmaniasis. J Exp Med 1989;169:59.
28. Clerici M, Shearer GM. A Th1 to Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14: 107-11.
29. Gazzinelli RtT, Makino M, Chattopakyay SK, Snapper CM, Sher A, Hugin AW, Morse HC III. CD4+ subset regulation in viral infection. J Immunol 1992;148:182-8.
30. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with down-regulation of inflammatory cytokines and differential upregulation of transforming growth factor, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992; 176:1355-64.
31. Chadwick VS, Anderson RP. Microorganisms and their products in inflammatory bowel disease. In: MacDermott RP, ed. Inflammatory bowel disease. Amsterdam: Elsevier, 1992:241-59.
32. Shalon L, Gulwani-Akolkar B, Fisher SE, Akolkar PN, Panja A, Mayer L, Silver J. Evidence for an altered T-cell receptor repertoire in Crohn's disease. Autoimmunity 1994;17:241-8.
33. Posnett DN, Schmelkin I, Burton DA, August A, McGrath H, Mayer LF. T cell antigen receptor V gene usage: increases in V beta 8+ T cells in Crohn's disease. J Clin Invest 1900;85:1770-6.
34. Mueller C, Knoflach P, Zilenski CC. T-cell activation in Crohn's disease: increased levels of soluble IL-2 receptor in the supernatants of stimulated peripheral mononuclear cells. Gastroenterology 1990;98:639-46.
35. Shanahan F, Deem R, Nayeersina R, Leman B, Targon S. Human mucosal T-cell cytotoxicity. Gastroenterology 1988; 94:960-7.
36. Fiocchi C, Tubbs RR, Youngman KR. Human intestinal mucosal mononuclear cells exhibit lymphokine-killer activity. Gastroenterology 1985;88:625-37.
37. Hogan PG, Hapel AJ, Doe WF. Lymphokine-activated and natural killer cell activity in human intestinal mucosa. J Immunol 1985;135:1731-39.
38. Fiocchi C, Youngmann KR, Yen-Lieberman B, Tubbs RR. Modulation of intestinal immune reactivity by interleukin-2: phenotypic and functional analysis of lymphokine-activated killer cells from human intestinal mucosa. Dig Dis Sci 1988;33:1305-15.
39. Kromer G, Wick G. The role of IL-2 in autoimmunity. Immunol Today 1989;10:246-51.
40. Cotran RS, Pober JS, Gimbrone JR, Springer TA, Wiebke EA, Gaspari AA, Rosenberg SA, Lotzke MT. Endothelial activation during IL-2 immunotherapy: a possible mechanism for the vascular leak syndrome. J Immunol 1988;140: 1883-8.
41. Katz KD, Hollander D, Vadheim CM, McEltree C, Delanhunty T, Dadufalza VD, Krugliak P, Rotter JI. Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology 1989;97:927-31.
42. Sparano JA, Brandt LJ, Dutcher JP, Duboia JS, Atkins MB. Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2. Ann Intern Med 1993;188: 617-8.
43. Paul WE, Ohara J. B cell stimulatory factor-1/interleukin-4. Annu Rev Immunol 1987;5:429.
44. Deem RL, Shanahan F, Targan SR. Triggered human mucosal T cells release tumor necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells. Clin Exp Immunol 1991;83:79-84.
45. Colgan SP, Parkos CA, Delp C, Arnout MA, Madara JL. Neutrophil migration across cultured epithelial monolayers is modulated by epithelial exposure to IFN-gamma in a highly polarized fashion. J Cell Biol 1993;120:785-98.
46. Kelly CP, Okeane JC, Ornella J, Schroy PC, Yang S, LaMont JT, Brady HR. Human colon cancer cells express ICAM-1 in vivo and support LFfA-1 dependent lymphocyte adhesion in vitro. Am J Physiol 1992;G864-70.
47. Breese E, Bragger CP, Corrigan CJ, Walker-Smith JA, MacDonald TT. Interleukin-2 and IFN-γ secreting T cells in normal and diseased intestinal mucosa. Immunology 1993;78: 127-31.
48. Mullin GE, Vezza FR, Sampat A, Maycon Z, Katz R, Weissman G, McKinley M, Fisher SE. Abnormal IL-10 mRNA production in the intestinal mucosal lesions of inflammatory bowel disease. Gastroenterology 1193;104:A751.
49. Takatsu K, Tominaga A. Interleukin 5 and its receptor. Prog Growth Factor Res 1991;3:87-102.
50. Takahashi F, Das KM. Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis. J Clin Invest 1985;76:311-8.
51. Shanahan F, Landers C, Duerr R, Targan S. Neutrophil autoantibodies and disease markers for ulcerative colitis. Immunol Res 1991;10:479-84.
52. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-61.
53. Strober W, Erhardt RO. Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice. Cell 1993;75:203-5.